ProCE Banner Activity

Clinical Updates on Noncovalent BTK Inhibitors in CLL and MCL


Using real-world case scenarios, learn more about the role and optimal use of noncovalent BTK inhibitors in the personalized care of patients with MCL or CLL/SLL.

Released: May 14, 2024

Expiration: May 13, 2025



Sandra E. Kurtin

Sandra E. Kurtin, PhD, ANP-BC, FAPO

Director, Advanced Practice and Clinical Integration
The University of Arizona Cancer Center
Assistant Professor of Clinical Medicine
Adjunct Clinical Assistant Professor of Nursing
The University of Arizona
Tucson, Arizona

Provided by

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme, LLC


Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner